473
On 6 November 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 407. The active ingredient is heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148 for prevention of necrotizing enterocolitis.